LAURA RUOFF: Open Payments
NPI 1679520324 · CAMBRIDGE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 8 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $27 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $26 |
| UCB, Inc. | 1 | $23 |
| ARGENX US, INC. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
| Biogen, Inc. | 1 | $18 |
Products named: BOTOX, Jornay PM, Briviact, VYVGART, INGREZZA, ARISTADA, AMYVID, ZURZUVAE.
Industry payments across MA — which companies pay providers there.
